Two sisters diagnosed with the same stage of breast cancer in the same spot three weeks apart take part in proton therapy trial, Mayo Clinic and Google Health partner to investigate the use of artificial intelligence in assisting with radiotherapy treatments and more from the weekly roundup of news and research happening in the cancer landscape.
Ultra-precise drug targeting brings new hope for patients with non-small cell lung cancer that harbors rare mutations.
Giving fewer courses of chemotherapy and no radiation could become a new standard for patients with stage 1 or 2 diffuse large B cell lymphoma based on the results of a recent study.
Here is a list of some recent trials that launched within the cancer space in October.
As colorectal cancer is becoming more prevalent in younger patients, the U.S. Preventive Services Task Force (USPSTF) introduced a draft recommendation that, if accepted, will lower the screening age from 50 years to 45 years in those with average risk.
5-year follow up data from a promising trial shows survival benefits with the combination treatment of Tafinlar and Mekinist with patients with melanoma.
A study assessing the value of movement found that it improved physical and mental health in older adults who had survived cancer, as well as those with no history of the disease.
A liquid biopsy may soon be available to find early signs of cancer in asymptomatic patients when the disease is still treatable and even curable.
A roundup of the latest news and updates for patients with breast cancer from CURE®.
In addition to showing clinically meaningful, durable responses, Tazverik (tazemetostat) was generally well-tolerated in heavily pretreated patients with relapsed or refractory follicular lymphoma, according to the results of an open-label, single-arm, multicenter phase 2 study.
Justice Amy Coney Barrett was sworn in to the Supreme Court on Tuesday. Her vote would be instrumental in deciding the fate of the Affordable Care Act. If it’s repealed during November’s landmark case, many could lose access to cancer screening and treatment.
The FDA granted a priority review to the biologics license application and new drug application for the combination of Opdivo and Cabometyx for patients with advanced kidney cancer.
A roundup of the latest news and updates for patients with myeloma from CURE®.
A meta-analysis of six clinical trials showed that standard treatment regimens for high-risk multiple myeloma may be more effective at delaying disease progression if they are given in combination with the targeted drug Darzalex (daratumumab).
The dependent coverage provision in the Affordable Care Act has helped adolescent and young adult patients with cancer stay on health insurance longer than those who had cancer before the ACA was signed into law.
Not everyone with myeloma needs to be treated right away, but when they do, there are some important upfront considerations for patients and providers.
Oncology nurses tend to the needs of patients with cancer with great care, but they also tend to the unspoken needs of their patients.
In this Extraordinary Healer® nomination essay, Alicia Castanon, M.S.N., OCN, APRN, FNP-C, proves herself as an exceptional teacher and oncology nurse.
Oncology nurses are the backbone of cancer care, and here's why they are cherished by patients and fellow nurses alike.
October is Breast Cancer Awareness month and is deeply associated with the color pink, but it wasn't always like that. Here's how the breast cancer awareness movement began.
From acclaimed actor Jeff Bridges tweeting about a new lymphoma diagnosis to controversial conservative radio host Rush Limbaugh announcing that his stage 4 lung cancer has progressed, here’s what’s happening in the cancer landscape this week.
Stephanie Walker, who was diagnosed with metastatic breast cancer in 2015, recalls how her disease has pulled the rug out from underneath her.
Treatments like kinase inhibitors are changing the options patient may have for when their breast cancer spreads to the brain.
Susan Swanson, who was diagnosed with metastatic breast cancer in 2014, says it’s very important for patients to surround themselves with a good support network.
Kirby Lewis, who was diagnosed with breast cancer in 2012 and whose disease metastasized in 2016, says his diagnosis helped his care team detect a heart condition.
“The future is not yours,” says Pam Haldeman, who has metastatic breast cancer. “A way to get back a little bit of control is to be your own advocate and get aggressive in researching and going to every conference or retreat available.”
The breast cancer patient advocacy movement that started in the 1950s pulled the disease out of the shadows, bringing patients’ options to light.
Two women living with metastatic breast cancer that has spread to the brain describe the tools that are helping to keep them alive.
“Most kinds of breast cancer are potentially curable, but metastatic breast cancer is not,” says Kathleen Friel, lab director at the Burke Neurological Institute of Weill Cornell Medicine. “People assume, ‘Oh, you must be fine because you look fine.’ It puts a lot of expectations on us that, if somehow we’re strong enough, then we’ll beat this disease.”
The FDA’s approval or Opdivo (nivolumab) and Yervoy (ipilimumab) for the frontline treatment of patients with unresectable malignant pleural mesothelioma was desperately needed, says a thoracic oncologist at Memorial Sloan Kettering Cancer center. However, some questions remain.
